Literature DB >> 29916143

Mast Cell Proteases Activate Astrocytes and Glia-Neurons and Release Interleukin-33 by Activating p38 and ERK1/2 MAPKs and NF-κB.

Duraisamy Kempuraj1,2, Ramasamy Thangavel3,4, Gvindhasamy Pushpavathi Selvakumar3,4, Mohammad Ejaz Ahmed3,4, Smita Zaheer4, Sudhanshu P Raikwar3,4, Haris Zahoor4, Daniyal Saeed4, Iuliia Dubova4, Gema Giler4, Shelby Herr4, Shankar S Iyer3,4, Asgar Zaheer5,6.   

Abstract

Inflammatory mediators released from activated microglia, astrocytes, neurons, and mast cells mediate neuroinflammation. Parkinson's disease (PD) is characterized by inflammation-dependent dopaminergic neurodegeneration in substantia nigra. 1-Methyl-4-phenylpyridinium (MPP+), a metabolite of parkinsonian neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), induces inflammatory mediators' release from brain cells and mast cells. Brain cells' interaction with mast cells is implicated in neuroinflammation. However, the exact mechanisms involved are not yet clearly understood. Mouse fetal brain-derived cultured primary astrocytes and glia-neurons were incubated with mouse mast cell protease-6 (MMCP-6) and MMCP-7, and mouse bone marrow-derived mast cells (BMMCs) were incubated with MPP+ and brain protein glia maturation factor (GMF). Interleukin-33 (IL-33) released from these cells was quantitated by enzyme-linked immunosorbent assay. Both MMCP-6 and MMCP-7 induced IL-33 release from astrocytes and glia-neurons. MPP+ and GMF were used as a positive control-induced IL-33 and reactive oxygen species expression in mast cells. Mast cell proteases and MPP+ activate p38 and extracellular signal-regulated kinases 1/2 (ERK1/2), mitogen-activated protein kinases (MAPKs), and transcription factor nuclear factor-kappa B (NF-κB) in astrocytes, glia-neurons, or mast cells. Addition of BMMCs from wt mice and transduction with adeno-GMF show higher chemokine (C-C motif) ligand 2 (CCL2) release. MPP+ activated glial cells and reduced microtubule-associated protein 2 (MAP-2) expression indicating neurodegeneration. IL-33 expression increased in the midbrain and striatum of PD brains as compared with age- and sex-matched control subjects. Glial cells and neurons interact with mast cells and accelerate neuroinflammation and these interactions can be explored as a new therapeutic target to treat PD.

Entities:  

Keywords:  Brain cells; Glia maturation factor; Interleukin-33; Mast cell proteases; Mast cells; Parkinson’s disease

Mesh:

Substances:

Year:  2018        PMID: 29916143      PMCID: PMC6298852          DOI: 10.1007/s12035-018-1177-7

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  80 in total

1.  Effects of glia maturation factor overexpression in primary astrocytes on MAP kinase activation, transcription factor activation, and neurotrophin secretion.

Authors:  A Zaheer; M A Yorek; R Lim
Journal:  Neurochem Res       Date:  2001-12       Impact factor: 3.996

2.  Impaired motor performance and learning in glia maturation factor-knockout mice.

Authors:  Ramon Lim; Asgar Zaheer; Houdy Khosravi; John H Freeman; Hunter E Halverson; John A Wemmie; Baoli Yang
Journal:  Brain Res       Date:  2004-10-22       Impact factor: 3.252

Review 3.  Protease-activated receptors: regulation of neuronal function.

Authors:  Toshiyuki Saito; Nigel W Bunnett
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

4.  Intravesical sodium hyaluronate inhibits the rat urinary mast cell mediator increase triggered by acute immobilization stress.

Authors:  W S Boucher; R Letourneau; M Huang; D Kempuraj; M Green; G R Sant; T C Theoharides
Journal:  J Urol       Date:  2002-01       Impact factor: 7.450

5.  Characterization of mast cell-committed progenitors present in human umbilical cord blood.

Authors:  D Kempuraj; H Saito; A Kaneko; K Fukagawa; M Nakayama; H Toru; M Tomikawa; H Tachimoto; M Ebisawa; A Akasawa; T Miyagi; H Kimura; T Nakajima; K Tsuji; T Nakahata
Journal:  Blood       Date:  1999-05-15       Impact factor: 22.113

6.  Apolipoprotein E protects against oxidative stress in mixed neuronal-glial cell cultures by reducing glutamate toxicity.

Authors:  Yoonki Lee; Mitsuo Aono; Daniel Laskowitz; David S Warner; Robert D Pearlstein
Journal:  Neurochem Int       Date:  2004-01       Impact factor: 3.921

Review 7.  Role of oxidants in mast cell activation.

Authors:  Yoshihiro Suzuki; Tetsuro Yoshimaru; Toshio Inoue; Osamu Niide; Chisei Ra
Journal:  Chem Immunol Allergy       Date:  2005

8.  Overexpression of glia maturation factor in astrocytes leads to immune activation of microglia through secretion of granulocyte-macrophage-colony stimulating factor.

Authors:  Asgar Zaheer; Satya N Mathur; Ramon Lim
Journal:  Biochem Biophys Res Commun       Date:  2002-06-07       Impact factor: 3.575

9.  Polyclonal antibody localizes glia maturation factor beta-like immunoreactivity in neurons and glia.

Authors:  B R Wang; A Zaheer; R Lim
Journal:  Brain Res       Date:  1992-09-18       Impact factor: 3.252

Review 10.  Protease-activated receptor 2: activation, signalling and function.

Authors:  G S Cottrell; S Amadesi; F Schmidlin; N Bunnett
Journal:  Biochem Soc Trans       Date:  2003-12       Impact factor: 5.407

View more
  24 in total

1.  Potential therapeutic targets for intracerebral hemorrhage-associated inflammation: An update.

Authors:  Honglei Ren; Ranran Han; Xuemei Chen; Xi Liu; Jieru Wan; Limin Wang; Xiuli Yang; Jian Wang
Journal:  J Cereb Blood Flow Metab       Date:  2020-05-19       Impact factor: 6.200

Review 2.  Brain Injury-Mediated Neuroinflammatory Response and Alzheimer's Disease.

Authors:  Duraisamy Kempuraj; Mohammad Ejaz Ahmed; Govindhasamy Pushpavathi Selvakumar; Ramasamy Thangavel; Arshdeep S Dhaliwal; Iuliia Dubova; Shireen Mentor; Keerthivaas Premkumar; Daniyal Saeed; Haris Zahoor; Sudhanshu P Raikwar; Smita Zaheer; Shankar S Iyer; Asgar Zaheer
Journal:  Neuroscientist       Date:  2019-05-16       Impact factor: 7.519

Review 3.  Next Generation Precision Medicine: CRISPR-mediated Genome Editing for the Treatment of Neurodegenerative Disorders.

Authors:  Sudhanshu P Raikwar; Nidhi S Kikkeri; Ragha Sakuru; Daniyal Saeed; Haris Zahoor; Keerthivaas Premkumar; Shireen Mentor; Ramasamy Thangavel; Iuliia Dubova; Mohammad Ejaz Ahmed; Govindhasamy P Selvakumar; Duraisamy Kempuraj; Smita Zaheer; Shankar S Iyer; Asgar Zaheer
Journal:  J Neuroimmune Pharmacol       Date:  2019-04-23       Impact factor: 4.147

4.  Effects of G-Rh2 on mast cell-mediated anaphylaxis via AKT-Nrf2/NF-κB and MAPK-Nrf2/NF-κB pathways.

Authors:  Chang Xu; Liangchang Li; Chongyang Wang; Jingzhi Jiang; Li Li; Lianhua Zhu; Shan Jin; Zhehu Jin; Jung Joon Lee; Guanhao Li; Guanghai Yan
Journal:  J Ginseng Res       Date:  2021-10-13       Impact factor: 5.735

5.  Glia Maturation Factor in the Pathogenesis of Alzheimer's disease.

Authors:  Swathi Beladakere Ramaswamy; Sachin M Bhagavan; Harleen Kaur; Gema E Giler; Duraisamy Kempuraj; Ramasamy Thangavel; Mohammad Ejaz Ahmed; Govindhasamy Pushpavathi Selvakumar; Sudhanshu P Raikwar; Smita Zaheer; Shankar S Iyer; Raghav Govindarajan; Asgar Zaheer
Journal:  Open Access J Neurol Neurosurg       Date:  2019-12-17

Review 6.  Psychological Stress-Induced Immune Response and Risk of Alzheimer's Disease in Veterans from Operation Enduring Freedom and Operation Iraqi Freedom.

Authors:  Duraisamy Kempuraj; Mohammad Ejaz Ahmed; Govindhasamy Pushpavathi Selvakumar; Ramasamy Thangavel; Sudhanshu P Raikwar; Smita A Zaheer; Shankar S Iyer; Casey Burton; Donald James; Asgar Zaheer
Journal:  Clin Ther       Date:  2020-03-14       Impact factor: 3.393

7.  Glia Maturation Factor and Mast Cell-Dependent Expression of Inflammatory Mediators and Proteinase Activated Receptor-2 in Neuroinflammation.

Authors:  Duraisamy Kempuraj; Govindhasamy Pushpavathi Selvakumar; Ramasamy Thangavel; Mohammad Ejaz Ahmed; Smita Zaheer; Keerthana Kuppamma Kumar; Anudeep Yelam; Harleen Kaur; Iuliia Dubova; Sudhanshu P Raikwar; Shankar S Iyer; Asgar Zaheer
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

8.  Mast Cell Activation, Neuroinflammation, and Tight Junction Protein Derangement in Acute Traumatic Brain Injury.

Authors:  Duraisamy Kempuraj; Mohammad Ejaz Ahmed; Govindhasamy Pushpavathi Selvakumar; Ramasamy Thangavel; Sudhanshu P Raikwar; Smita A Zaheer; Shankar S Iyer; Casey Burton; Donald James; Asgar Zaheer
Journal:  Mediators Inflamm       Date:  2020-06-24       Impact factor: 4.711

Review 9.  Therapeutic Opportunities of Interleukin-33 in the Central Nervous System.

Authors:  Yun Sun; Yankai Wen; Luxi Wang; Liang Wen; Wendong You; Shuang Wei; Lin Mao; Hao Wang; Zuobing Chen; Xiaofeng Yang
Journal:  Front Immunol       Date:  2021-05-17       Impact factor: 7.561

Review 10.  The interplay between mast cells, pineal gland, and circadian rhythm: Links between histamine, melatonin, and inflammatory mediators.

Authors:  Linh Pham; Leonardo Baiocchi; Lindsey Kennedy; Keisaku Sato; Vik Meadows; Fanyin Meng; Chiung-Kuei Huang; Debjyoti Kundu; Tianhao Zhou; Lixian Chen; Gianfranco Alpini; Heather Francis
Journal:  J Pineal Res       Date:  2020-11-29       Impact factor: 12.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.